Skip to main content
. 2024 Oct 9;16(19):12769–12780. doi: 10.18632/aging.205707

Figure 1.

Figure 1

Bezafibrate improved cardiac function after coronary microembolization (CME) induction. (A) Left ventricular ejection fraction (LVEF); (B) Left ventricular fractional shortening (LVFS); (C) Cardiac output (CO); (D) Left ventricular end-diastolic diameter (LVEDd) (n=12, **, p<0.01 vs. control group; #, ##, p<0.05, 0.01 vs. CME group).